Almirall S.A.
Global biopharmaceutical company specializing in medical dermatology and skin health.
ALM | MC
Overview
Corporate Details
- ISIN(s):
- ES0157097017
- LEI:
- 95980020140005007996
- Country:
- Spain
- Address:
- Ronda General Mitre 151, 08022 Barcelona
- Website:
- http://www.almirall.com
- Sector:
- Manufacturing
Description
Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-02 07:27 |
Información sobre dividendos
|
Spanish | 212.9 KB | ||
| 2020-09-28 09:03 |
El Consejero Delegado ha decidido dejar Almirall el próximo 31.12.2020
|
Spanish | 797.4 KB | ||
| 2020-09-17 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-09-07 17:55 |
La Sociedad comunica el calendario del dividendo flexible.
|
Spanish | 331.7 KB | ||
| 2020-07-30 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-07-27 19:05 |
La Sociedad informa de las operaciones realizadas en el sexto trimestre de vige…
|
Spanish | 219.0 KB | ||
| 2020-07-24 17:24 |
Comisión de Dermatología de la Compañía
|
Spanish | 24.1 KB | ||
| 2020-07-20 17:37 |
Almirall refinancia la línea de crédito revolving
|
Spanish | 172.9 KB | ||
| 2020-06-25 19:15 |
Almirall S.A. desinvierte Ansiolin® a Neuraxpharm en Italia
|
Spanish | 25.4 KB | ||
| 2020-06-10 17:39 |
Convocatoria Junta General Ordinaria para su celebración por medios exclusivame…
|
Spanish | 643.9 KB | ||
| 2020-05-11 07:36 |
Almirall mantendrá una teleconferencia con analistas e inversores
|
Spanish | 115.1 KB | ||
| 2020-05-06 18:19 |
Operaciones del contrato de liquidez durante el primer trimestre de 2020
|
Portuguese | 576.0 KB | ||
| 2020-03-24 17:44 |
Junta General Ordinaria de Accionistas
|
Spanish | 24.2 KB | ||
| 2020-03-13 00:00 |
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | ||
| 2020-03-09 12:11 |
Almirall anuncia que la FDA ha aceptado la presentación de la solicitud para ti…
|
Spanish | 17.9 KB |
Automate Your Workflow. Get a real-time feed of all Almirall S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Almirall S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Almirall S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
